Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Low Field Magnetic Stimulation: Open Label Study.
Low Field Magnetic Stimulation: Open Label Study.
Status: Enrolling
Updated:  4/12/2016
McLean Hospital
mi
from
Belmont, MA
Low Field Magnetic Stimulation: Open Label Study.
Low Field Magnetic Stimulation: Open Label Study.
Status: Enrolling
Updated: 4/12/2016
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD)
A Dose Escalation Study of Intranasal Neuropeptide Y in PTSD
Status: Enrolling
Updated:  4/13/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD)
A Dose Escalation Study of Intranasal Neuropeptide Y in PTSD
Status: Enrolling
Updated: 4/13/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Treating Oxidative Stress in Children With Autism
Efficacy of Methylcobalamin and Folinic Acid Treatment on Glutathione Redox Status and Core Behavior in Children With Autism
Status: Enrolling
Updated:  4/13/2016
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Treating Oxidative Stress in Children With Autism
Efficacy of Methylcobalamin and Folinic Acid Treatment on Glutathione Redox Status and Core Behavior in Children With Autism
Status: Enrolling
Updated: 4/13/2016
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Click here to add this to my saved trials
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Characterization of Potential Biomarkers to Assess Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Status: Enrolling
Updated:  4/14/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Characterization of Potential Biomarkers to Assess Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
Status: Enrolling
Updated: 4/14/2016
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Eszopiclone for the Treatment of Posttraumatic Stress Disorder
Eszopiclone for the Treatment of PTSD
Status: Enrolling
Updated:  4/14/2016
Center for Anxiety and Traumatic Stress Disorders at Rush
mi
from
Chicago, IL
Eszopiclone for the Treatment of Posttraumatic Stress Disorder
Eszopiclone for the Treatment of PTSD
Status: Enrolling
Updated: 4/14/2016
Center for Anxiety and Traumatic Stress Disorders at Rush
mi
from
Chicago, IL
Click here to add this to my saved trials
Integrated Collaborative Care for Substance Use Disorders
Integrated Collaborative Care for Substance Use Disorders
Status: Enrolling
Updated:  4/15/2016
Venice Family Clinic-Simms Mann Health Center
mi
from
Santa Monica, CA
Integrated Collaborative Care for Substance Use Disorders
Integrated Collaborative Care for Substance Use Disorders
Status: Enrolling
Updated: 4/15/2016
Venice Family Clinic-Simms Mann Health Center
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Integrated Collaborative Care for Substance Use Disorders
Integrated Collaborative Care for Substance Use Disorders
Status: Enrolling
Updated:  4/15/2016
Venice Family Clinic-Rose lAvenue
mi
from
Venice, CA
Integrated Collaborative Care for Substance Use Disorders
Integrated Collaborative Care for Substance Use Disorders
Status: Enrolling
Updated: 4/15/2016
Venice Family Clinic-Rose lAvenue
mi
from
Venice, CA
Click here to add this to my saved trials
Substance Use and Sexual Risk Reduction Intervention for Homeless Youth
Brief AOD Use and Sexual Risk Reduction Group MI Intervention for Homeless
Status: Enrolling
Updated:  4/15/2016
My Friend's Place
mi
from
Hollywood, CA
Substance Use and Sexual Risk Reduction Intervention for Homeless Youth
Brief AOD Use and Sexual Risk Reduction Group MI Intervention for Homeless
Status: Enrolling
Updated: 4/15/2016
My Friend's Place
mi
from
Hollywood, CA
Click here to add this to my saved trials
Substance Use and Sexual Risk Reduction Intervention for Homeless Youth
Brief AOD Use and Sexual Risk Reduction Group MI Intervention for Homeless
Status: Enrolling
Updated:  4/15/2016
Safe Place for Youth
mi
from
Venice Beach, CA
Substance Use and Sexual Risk Reduction Intervention for Homeless Youth
Brief AOD Use and Sexual Risk Reduction Group MI Intervention for Homeless
Status: Enrolling
Updated: 4/15/2016
Safe Place for Youth
mi
from
Venice Beach, CA
Click here to add this to my saved trials
Investigation of Neuroserpin as an Autism Candidate Gene
Investigation of Neuroserpin as an Autism Candidate Gene
Status: Enrolling
Updated:  4/18/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Investigation of Neuroserpin as an Autism Candidate Gene
Investigation of Neuroserpin as an Autism Candidate Gene
Status: Enrolling
Updated: 4/18/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Intensive Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)
Intensive Treatment of Chronic Pain and PTSD for OEF/OIF Veterans
Status: Enrolling
Updated:  4/18/2016
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
mi
from
West Haven, CT
Intensive Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)
Intensive Treatment of Chronic Pain and PTSD for OEF/OIF Veterans
Status: Enrolling
Updated: 4/18/2016
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
mi
from
West Haven, CT
Click here to add this to my saved trials
Intensive Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)
Intensive Treatment of Chronic Pain and PTSD for OEF/OIF Veterans
Status: Enrolling
Updated:  4/18/2016
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
Intensive Treatment for Chronic Pain and Posttraumatic Stress Disorder (PTSD)
Intensive Treatment of Chronic Pain and PTSD for OEF/OIF Veterans
Status: Enrolling
Updated: 4/18/2016
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
Click here to add this to my saved trials
Improving Buprenorphine Detoxification Outcomes With Isradipine
Improving Buprenorphine Detoxification Outcomes With Isradipine
Status: Enrolling
Updated:  4/18/2016
UAMS Psychiatric Research Institute
mi
from
Little Rock, AR
Improving Buprenorphine Detoxification Outcomes With Isradipine
Improving Buprenorphine Detoxification Outcomes With Isradipine
Status: Enrolling
Updated: 4/18/2016
UAMS Psychiatric Research Institute
mi
from
Little Rock, AR
Click here to add this to my saved trials
Screening, Brief Intervention, and Referral to Treatment for Drug Use
Screening and Brief Intervention for Latino and Non-Latino White Drug Users
Status: Enrolling
Updated:  4/18/2016
Scripps Mercy Emergency Department and Trauma Unit
mi
from
San Diego, CA
Screening, Brief Intervention, and Referral to Treatment for Drug Use
Screening and Brief Intervention for Latino and Non-Latino White Drug Users
Status: Enrolling
Updated: 4/18/2016
Scripps Mercy Emergency Department and Trauma Unit
mi
from
San Diego, CA
Click here to add this to my saved trials
Screening, Brief Intervention, and Referral to Treatment for Drug Use
Screening and Brief Intervention for Latino and Non-Latino White Drug Users
Status: Enrolling
Updated:  4/18/2016
UCSD Emergency Department and Trauma Unit
mi
from
San Diego, CA
Screening, Brief Intervention, and Referral to Treatment for Drug Use
Screening and Brief Intervention for Latino and Non-Latino White Drug Users
Status: Enrolling
Updated: 4/18/2016
UCSD Emergency Department and Trauma Unit
mi
from
San Diego, CA
Click here to add this to my saved trials
Social Cognition Intervention
Augmenting Social Cognitive Intervention for Veterans With Schizophrenia
Status: Enrolling
Updated:  4/20/2016
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Social Cognition Intervention
Augmenting Social Cognitive Intervention for Veterans With Schizophrenia
Status: Enrolling
Updated: 4/20/2016
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress Disorder
Cognitive Behavioral Therapy vs. Sertraline in the Treatment of Post Traumatic Stress Disorder
Status: Enrolling
Updated:  4/21/2016
NYU Institute for Trauma & Resilience
mi
from
New York, NY
Cognitive Behavioral Therapy Versus Sertraline in the Treatment of Post-Traumatic Stress Disorder
Cognitive Behavioral Therapy vs. Sertraline in the Treatment of Post Traumatic Stress Disorder
Status: Enrolling
Updated: 4/21/2016
NYU Institute for Trauma & Resilience
mi
from
New York, NY
Click here to add this to my saved trials
University of California, San Diego (UCSD) Suramin Treatment Trial for Autism
The UCSD Suramin Autism Treatment Trial
Status: Enrolling
Updated:  4/25/2016
University of California, San Diego, School of Medicine
mi
from
La Jolla, CA
University of California, San Diego (UCSD) Suramin Treatment Trial for Autism
The UCSD Suramin Autism Treatment Trial
Status: Enrolling
Updated: 4/25/2016
University of California, San Diego, School of Medicine
mi
from
La Jolla, CA
Click here to add this to my saved trials
The Use of Propranolol to Block Memory Reconsolidation in PTSD
The Use of Propranolol to Block Memory Reconsolidation in Post Traumatic Stress Disorders (PTSD)
Status: Enrolling
Updated:  4/26/2016
John D Dingell VA Hospital
mi
from
Detroit, MI
The Use of Propranolol to Block Memory Reconsolidation in PTSD
The Use of Propranolol to Block Memory Reconsolidation in Post Traumatic Stress Disorders (PTSD)
Status: Enrolling
Updated: 4/26/2016
John D Dingell VA Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Dog Adoption in Veterans With Posttraumatic Stress Disorder (PTSD)
A Study of Dog Adoption in Veterans With Posttraumatic Stress Disorder
Status: Enrolling
Updated:  4/26/2016
South Texas Health Care System, San Antonio, TX
mi
from
San Antonio, TX
A Study of Dog Adoption in Veterans With Posttraumatic Stress Disorder (PTSD)
A Study of Dog Adoption in Veterans With Posttraumatic Stress Disorder
Status: Enrolling
Updated: 4/26/2016
South Texas Health Care System, San Antonio, TX
mi
from
San Antonio, TX
Click here to add this to my saved trials
Improving Hospitalizations for Children With ASD
Improving Hospitalizations for Children With ASD: Testing the Cost and Clinical Efficacy of Integrated Behavioral Intervention
Status: Enrolling
Updated:  4/26/2016
Vanderbilt University Medical Center - MEND Clinic
mi
from
Nashville, TN
Improving Hospitalizations for Children With ASD
Improving Hospitalizations for Children With ASD: Testing the Cost and Clinical Efficacy of Integrated Behavioral Intervention
Status: Enrolling
Updated: 4/26/2016
Vanderbilt University Medical Center - MEND Clinic
mi
from
Nashville, TN
Click here to add this to my saved trials
A mGlu2/3 Agonist in the Treatment of PTSD
A mGlu2/3 Agonist in the Treatment of PTSD
Status: Enrolling
Updated:  4/29/2016
NYU School of Medicine
mi
from
New York, NY
A mGlu2/3 Agonist in the Treatment of PTSD
A mGlu2/3 Agonist in the Treatment of PTSD
Status: Enrolling
Updated: 4/29/2016
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Status: Enrolling
Updated:  5/2/2016
Northwest Christian University
mi
from
Eugene, OR
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Status: Enrolling
Updated: 5/2/2016
Northwest Christian University
mi
from
Eugene, OR
Click here to add this to my saved trials
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Status: Enrolling
Updated:  5/2/2016
University of Oregon
mi
from
Eugene, OR
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Status: Enrolling
Updated: 5/2/2016
University of Oregon
mi
from
Eugene, OR
Click here to add this to my saved trials
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Status: Enrolling
Updated:  5/2/2016
Univ of Pennsylvania
mi
from
Philadelphia, PA
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Status: Enrolling
Updated: 5/2/2016
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Status: Enrolling
Updated:  5/2/2016
Temple University
mi
from
Philadelphia, PA
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Status: Enrolling
Updated: 5/2/2016
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Status: Enrolling
Updated:  5/2/2016
University of Texas at Austin
mi
from
Austin, TX
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Status: Enrolling
Updated: 5/2/2016
University of Texas at Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Status: Enrolling
Updated:  5/2/2016
Southwestern University
mi
from
Georgetown, TX
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Status: Enrolling
Updated: 5/2/2016
Southwestern University
mi
from
Georgetown, TX
Click here to add this to my saved trials
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Status: Enrolling
Updated:  5/2/2016
Drexel University
mi
from
Philadelphia, PA
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students
Status: Enrolling
Updated: 5/2/2016
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Individual vs. Group Community Reinforcement Training to Help Parents of Substance-using Treatment-refusing Youth
Group Community Reinforcement Training for Parents of Treatment-Elusive Youth
Status: Enrolling
Updated:  5/2/2016
Center for Family and Adolescent Research
mi
from
Portland, OR
Individual vs. Group Community Reinforcement Training to Help Parents of Substance-using Treatment-refusing Youth
Group Community Reinforcement Training for Parents of Treatment-Elusive Youth
Status: Enrolling
Updated: 5/2/2016
Center for Family and Adolescent Research
mi
from
Portland, OR
Click here to add this to my saved trials
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  5/2/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 5/2/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  5/2/2016
Clinical Research Facility
mi
from
Sacramento, CA
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 5/2/2016
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  5/2/2016
Clinical Research Facility
mi
from
Santa Monica, CA
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 5/2/2016
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  5/2/2016
Clinical Research Facility
mi
from
Washington,
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 5/2/2016
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  5/2/2016
Clinical Research Facility
mi
from
Tampa, FL
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 5/2/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  5/2/2016
Clinical Research Facility
mi
from
Chicago, IL
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 5/2/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  5/2/2016
Clinical Research Facility
mi
from
Detroit, MI
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 5/2/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  5/2/2016
Clinical Research Facility
mi
from
Las Vegas, NV
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 5/2/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  5/2/2016
Clinical Research Facility
mi
from
Hackensack, NJ
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 5/2/2016
Clinical Research Facility
mi
from
Hackensack, NJ
Click here to add this to my saved trials
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  5/2/2016
Clinical Research Facility
mi
from
Huntersville, NC
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 5/2/2016
Clinical Research Facility
mi
from
Huntersville, NC
Click here to add this to my saved trials
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  5/2/2016
Clinical Research Facility
mi
from
Portland, OR
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 5/2/2016
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  5/2/2016
Clinical Research Facility
mi
from
Memphis, TN
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 5/2/2016
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated:  5/2/2016
Clinical Research Facility
mi
from
Houston, TX
A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies
A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination With Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects With Selected Advanced Solid Tumors or Aggressive B-cell Lymphomas
Status: Enrolling
Updated: 5/2/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Smartphone Technology and CBT-GSH in Binge Eaters
Innovative Use of the Noom Monitor Mobile Application for CBT-GSH in Binge Eaters
Status: Enrolling
Updated:  5/2/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Smartphone Technology and CBT-GSH in Binge Eaters
Innovative Use of the Noom Monitor Mobile Application for CBT-GSH in Binge Eaters
Status: Enrolling
Updated: 5/2/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth
Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth
Status: Enrolling
Updated:  5/3/2016
Medical University of South Carolina
mi
from
Charleston, SC
Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth
Targeting HIV Risk Behaviors in Juvenile Drug Court-Involved Youth
Status: Enrolling
Updated: 5/3/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Wellness Self-Management
A Hybrid Effectiveness-Implementation Trial of a Wellness Self-Management Program
Status: Enrolling
Updated:  5/3/2016
Washington DC VA Medical Center, Washington, DC
mi
from
Washington,
Wellness Self-Management
A Hybrid Effectiveness-Implementation Trial of a Wellness Self-Management Program
Status: Enrolling
Updated: 5/3/2016
Washington DC VA Medical Center, Washington, DC
mi
from
Washington,
Click here to add this to my saved trials
Wellness Self-Management
A Hybrid Effectiveness-Implementation Trial of a Wellness Self-Management Program
Status: Enrolling
Updated:  5/3/2016
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Wellness Self-Management
A Hybrid Effectiveness-Implementation Trial of a Wellness Self-Management Program
Status: Enrolling
Updated: 5/3/2016
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Click here to add this to my saved trials
CB1 Receptor PET Imaging Reveals Gender Differences in PTSD
Cannabinoid-1 (CB1) Receptor Positron Emission Tomography (PET) Imaging Reveals Gender Differences in Posttraumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  5/3/2016
NYU School of Medicine
mi
from
New York, NY
CB1 Receptor PET Imaging Reveals Gender Differences in PTSD
Cannabinoid-1 (CB1) Receptor Positron Emission Tomography (PET) Imaging Reveals Gender Differences in Posttraumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 5/3/2016
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Mobile App for Mood in Pregnancy (Ginger iO)
Status: Enrolling
Updated:  5/3/2016
Dickens Center for Women's Health at the Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Mobile App for Mood in Pregnancy (Ginger iO)
Status: Enrolling
Updated: 5/3/2016
Dickens Center for Women's Health at the Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers
Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers
Status: Enrolling
Updated:  5/4/2016
Texas Children's Hospital
mi
from
Houston, TX
Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers
Efficacy of a Brief Behavioral Intervention to Treat ADHD and Disruptive Behaviors In Preschoolers
Status: Enrolling
Updated: 5/4/2016
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials